Related Experiment Video
Updated: Jul 26, 2026

11:19
Silk Film Culture System for in vitro Analysis and Biomaterial Design
Published on: April 24, 2012
In vitro study of drug-loaded bioresorbable films and support structures
M Zilberman1, R C Eberhart, N D Schwade
1Department of Biomedical Engineering, Faculty of Engineering, Tel Aviv University, Tel Aviv 69978, Israel. meitalz@eng.tau.ac.il
Journal of Biomaterials Science. Polymer Edition
|January 10, 2003
Summary
This study developed bioresorbable poly(L-lactic acid) stents for tracheal support. These drug-eluting stents offer mechanical stability and degrade over time, eliminating removal surgery.
Area of Science:
- Biomaterials Science
- Polymer Chemistry
- Regenerative Medicine
Background:
- Bioresorbable films offer dual functionality as support structures and drug delivery systems.
- Poly(L-lactic acid) (PLLA) is a promising material for medical implants due to its biocompatibility and degradability.
Purpose of the Study:
- To develop and characterize bioresorbable PLLA films and stents containing dexamethasone for potential use in supporting body conduits.
- To evaluate the mechanical properties, degradation behavior, and drug release kinetics of these PLLA-based devices.
Main Methods:
- Solution processing of PLLA films incorporating dexamethasone.
- In vitro mechanical testing, morphological analysis, and degradation studies.
- Assessment of drug release profiles and stent performance under radial compression.
Main Results:
- PLLA films exhibited good initial mechanical properties and accommodated dexamethasone incorporation.
- Water incubation led to decreased mechanical properties due to degradation and morphological changes.
- Dexamethasone release was linear and dependent on film structure; stents showed good mechanical properties and potential for supporting conduits over 20 weeks.
Conclusions:
- Bioresorbable PLLA films and stents are viable for drug delivery and structural support applications.
- The mechanical integrity and degradation of these devices can be tailored by polymer structure and drug incorporation.
- These findings support the potential clinical application of these stents for conditions like neonatal tracheal malacia.

